Annual gross profit:
$38.90B+$4.71B(+13.77%)Summary
- As of today (April 16, 2025), NVS annual gross profit is $38.90 billion, with the most recent change of +$4.71 billion (+13.77%) on December 31, 2024.
- During the last 3 years, NVS annual gross profit has risen by +$6.66 billion (+20.65%).
- NVS annual gross profit is now -3.71% below its all-time high of $40.39 billion, reached on December 31, 2011.
Performance
NVS Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$10.23B+$296.00M(+2.98%)Summary
- As of today (April 16, 2025), NVS quarterly gross profit is $10.23 billion, with the most recent change of +$296.00 million (+2.98%) on December 31, 2024.
- Over the past year, NVS quarterly gross profit has increased by +$535.00 million (+5.52%).
- NVS quarterly gross profit is now -2.57% below its all-time high of $10.50 billion, reached on June 30, 2011.
Performance
NVS quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$38.90B+$1.48B(+3.96%)Summary
- As of today (April 16, 2025), NVS TTM gross profit is $38.90 billion, with the most recent change of +$1.48 billion (+3.96%) on December 31, 2024.
- Over the past year, NVS TTM gross profit has increased by +$2.44 billion (+6.70%).
- NVS TTM gross profit is now -3.85% below its all-time high of $40.45 billion, reached on September 30, 2011.
Performance
NVS TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
NVS Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.8% | +5.5% | +6.7% |
| 3 y3 years | +20.6% | +29.4% | +25.6% |
| 5 y5 years | +13.6% | +24.9% | +12.4% |
NVS Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.0% | at high | +29.4% | at high | +25.6% |
| 5 y | 5-year | at high | +22.0% | at high | +114.3% | at high | +25.6% |
| alltime | all time | -3.7% | +177.5% | -2.6% | +217.8% | -3.9% | +1107.9% |
Novartis AG Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $38.90B(+13.8%) | $10.23B(+3.0%) | $38.90B(+4.0%) |
| Sep 2024 | - | $9.94B(+2.5%) | $37.41B(+2.6%) |
| Jun 2024 | - | $9.70B(+7.5%) | $36.45B(+3.7%) |
| Mar 2024 | - | $9.02B(+3.1%) | $35.16B(+2.8%) |
| Dec 2023 | $34.19B(+7.2%) | $8.75B(-2.5%) | $34.19B(+2.5%) |
| Sep 2023 | - | $8.97B(+6.8%) | $33.36B(+3.3%) |
| Jun 2023 | - | $8.40B(+4.3%) | $32.29B(-2.8%) |
| Mar 2023 | - | $8.06B(+1.7%) | $33.22B(-2.6%) |
| Dec 2022 | $31.88B(-1.1%) | $7.92B(+0.2%) | $34.13B(+10.2%) |
| Sep 2022 | - | $7.91B(-15.3%) | $30.98B(-4.7%) |
| Jun 2022 | - | $9.33B(+4.2%) | $32.50B(-0.1%) |
| Mar 2022 | - | $8.96B(+87.6%) | $32.54B(+0.9%) |
| Dec 2021 | $32.24B(-7.3%) | $4.78B(-49.4%) | $32.24B(-11.1%) |
| Sep 2021 | - | $9.43B(+0.5%) | $36.28B(+1.8%) |
| Jun 2021 | - | $9.38B(+8.4%) | $35.63B(+3.4%) |
| Mar 2021 | - | $8.65B(-1.8%) | $34.45B(-1.0%) |
| Dec 2020 | $34.78B(+1.5%) | $8.81B(+0.3%) | $34.78B(+0.3%) |
| Sep 2020 | - | $8.79B(+7.2%) | $34.69B(+0.2%) |
| Jun 2020 | - | $8.19B(-8.8%) | $34.61B(-1.2%) |
| Mar 2020 | - | $8.99B(+3.0%) | $35.03B(+2.3%) |
| Dec 2019 | $34.25B(+8.4%) | $8.72B(+0.2%) | $34.25B(+2.6%) |
| Sep 2019 | - | $8.71B(+1.0%) | $33.39B(+2.4%) |
| Jun 2019 | - | $8.62B(+5.0%) | $32.60B(+1.6%) |
| Mar 2019 | - | $8.20B(+4.4%) | $32.08B(+1.6%) |
| Dec 2018 | $31.59B(+6.1%) | $7.86B(-0.8%) | $31.59B(+8.1%) |
| Sep 2018 | - | $7.92B(-2.1%) | $29.22B(-1.5%) |
| Jun 2018 | - | $8.10B(+5.0%) | $29.66B(-0.5%) |
| Mar 2018 | - | $7.71B(+40.6%) | $29.80B(+0.1%) |
| Dec 2017 | $29.77B(-6.7%) | $5.49B(-34.4%) | $29.77B(-8.1%) |
| Sep 2017 | - | $8.37B(+1.6%) | $32.40B(+1.2%) |
| Jun 2017 | - | $8.24B(+7.2%) | $32.01B(+0.0%) |
| Mar 2017 | - | $7.68B(-5.4%) | $32.00B(+0.3%) |
| Dec 2016 | $31.92B(-3.2%) | $8.12B(+1.8%) | $31.92B(-0.4%) |
| Sep 2016 | - | $7.97B(-3.1%) | $32.05B(-0.4%) |
| Jun 2016 | - | $8.23B(+8.3%) | $32.18B(-0.6%) |
| Mar 2016 | - | $7.60B(-8.0%) | $32.36B(-1.9%) |
| Dec 2015 | $32.98B(-9.1%) | $8.26B(+2.0%) | $32.98B(-2.0%) |
| Sep 2015 | - | $8.10B(-3.7%) | $33.67B(-2.3%) |
| Jun 2015 | - | $8.41B(+2.3%) | $34.45B(-3.3%) |
| Mar 2015 | - | $8.22B(-8.0%) | $35.61B(-1.9%) |
| Dec 2014 | $36.29B(+0.4%) | $8.94B(+0.7%) | $36.29B(-0.7%) |
| Sep 2014 | - | $8.88B(-7.2%) | $36.55B(+0.3%) |
| Jun 2014 | - | $9.57B(+7.5%) | $36.45B(+1.0%) |
| Mar 2014 | - | $8.90B(-3.3%) | $36.07B(-1.9%) |
| Dec 2013 | $36.14B(+0.1%) | $9.20B(+4.8%) | $36.77B(+5.5%) |
| Sep 2013 | - | $8.78B(-4.5%) | $34.85B(-1.9%) |
| Jun 2013 | - | $9.19B(-4.2%) | $35.54B(-2.0%) |
| Mar 2013 | - | $9.60B(+31.9%) | $36.28B(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $36.10B(-10.6%) | $7.28B(-23.1%) | $36.10B(-6.7%) |
| Sep 2012 | - | $9.46B(-4.7%) | $38.70B(-2.0%) |
| Jun 2012 | - | $9.93B(+5.3%) | $39.48B(-1.4%) |
| Mar 2012 | - | $9.43B(-4.5%) | $40.06B(-0.8%) |
| Dec 2011 | $40.39B(+9.0%) | $9.88B(-3.6%) | $40.39B(-0.2%) |
| Sep 2011 | - | $10.25B(-2.5%) | $40.45B(+2.8%) |
| Jun 2011 | - | $10.50B(+7.6%) | $39.37B(+4.8%) |
| Mar 2011 | - | $9.76B(-1.8%) | $37.58B(+1.4%) |
| Dec 2010 | $37.07B(+12.6%) | $9.94B(+8.5%) | $37.07B(+1.3%) |
| Sep 2010 | - | $9.16B(+5.1%) | $36.61B(+2.7%) |
| Jun 2010 | - | $8.71B(-5.9%) | $35.64B(+2.3%) |
| Mar 2010 | - | $9.26B(-2.3%) | $34.84B(+6.6%) |
| Dec 2009 | $32.92B(+5.7%) | $9.48B(+15.8%) | $32.70B(+6.4%) |
| Sep 2009 | - | $8.19B(+3.4%) | $30.74B(+0.6%) |
| Jun 2009 | - | $7.92B(+11.2%) | $30.56B(-0.4%) |
| Mar 2009 | - | $7.12B(-5.3%) | $30.70B(-1.4%) |
| Dec 2008 | $31.14B(+11.6%) | $7.51B(-6.2%) | $31.14B(+1.2%) |
| Sep 2008 | - | $8.01B(-0.6%) | $30.79B(+4.1%) |
| Jun 2008 | - | $8.05B(+6.4%) | $29.56B(+4.1%) |
| Mar 2008 | - | $7.57B(+5.7%) | $28.41B(+2.5%) |
| Dec 2007 | $27.91B(+8.6%) | $7.16B(+5.5%) | $27.73B(+0.7%) |
| Sep 2007 | - | $6.78B(-1.7%) | $27.55B(+1.1%) |
| Jun 2007 | - | $6.90B(+0.2%) | $27.26B(+2.3%) |
| Mar 2007 | - | $6.89B(-1.3%) | $26.64B(+3.6%) |
| Dec 2006 | $25.69B(+15.1%) | $6.98B(+7.4%) | $25.72B(+8.8%) |
| Sep 2006 | - | $6.50B(+3.4%) | $23.64B(+2.0%) |
| Jun 2006 | - | $6.28B(+5.3%) | $23.18B(+1.7%) |
| Mar 2006 | - | $5.97B(+22.0%) | $22.79B(+2.2%) |
| Dec 2005 | $22.31B(+8.4%) | $4.89B(-19.0%) | $22.31B(+1.1%) |
| Sep 2005 | - | $6.04B(+2.4%) | $22.07B(+2.8%) |
| Jun 2005 | - | $5.89B(+7.4%) | $21.48B(+2.5%) |
| Mar 2005 | - | $5.49B(+18.0%) | $20.96B(+1.9%) |
| Dec 2004 | $20.58B(+11.4%) | $4.65B(-14.6%) | $20.58B(+0.1%) |
| Sep 2004 | - | $5.44B(+1.2%) | $20.55B(+3.7%) |
| Jun 2004 | - | $5.38B(+5.4%) | $19.82B(+3.1%) |
| Mar 2004 | - | $5.10B(+10.3%) | $19.22B(+4.0%) |
| Dec 2003 | $18.47B(+16.3%) | $4.63B(-1.8%) | $18.47B(+2.3%) |
| Sep 2003 | - | $4.71B(-1.5%) | $18.07B(+5.0%) |
| Jun 2003 | - | $4.78B(+9.7%) | $17.20B(+2.9%) |
| Mar 2003 | - | $4.36B(+3.3%) | $16.73B(+35.2%) |
| Dec 2002 | $15.88B(+13.3%) | $4.22B(+9.6%) | $12.37B(+51.8%) |
| Sep 2002 | - | $3.85B(-10.5%) | $8.15B(+89.5%) |
| Jun 2002 | - | $4.30B(+32.3%) | $4.30B(+32.3%) |
| Dec 2001 | $14.02B(-11.5%) | - | - |
| Jun 2001 | - | $3.25B(+1.0%) | $3.25B(+1.0%) |
| Dec 2000 | $15.84B(+4.4%) | - | - |
| Jun 2000 | - | $3.22B | $3.22B |
| Dec 1999 | $15.16B(-3.6%) | - | - |
| Dec 1998 | $15.73B | - | - |
FAQ
- What is Novartis AG annual gross profit?
- What is the all time high annual gross profit for Novartis AG?
- What is Novartis AG annual gross profit year-on-year change?
- What is Novartis AG quarterly gross profit?
- What is the all time high quarterly gross profit for Novartis AG?
- What is Novartis AG quarterly gross profit year-on-year change?
- What is Novartis AG TTM gross profit?
- What is the all time high TTM gross profit for Novartis AG?
- What is Novartis AG TTM gross profit year-on-year change?
What is Novartis AG annual gross profit?
The current annual gross profit of NVS is $38.90B
What is the all time high annual gross profit for Novartis AG?
Novartis AG all-time high annual gross profit is $40.39B
What is Novartis AG annual gross profit year-on-year change?
Over the past year, NVS annual gross profit has changed by +$4.71B (+13.77%)
What is Novartis AG quarterly gross profit?
The current quarterly gross profit of NVS is $10.23B
What is the all time high quarterly gross profit for Novartis AG?
Novartis AG all-time high quarterly gross profit is $10.50B
What is Novartis AG quarterly gross profit year-on-year change?
Over the past year, NVS quarterly gross profit has changed by +$535.00M (+5.52%)
What is Novartis AG TTM gross profit?
The current TTM gross profit of NVS is $38.90B
What is the all time high TTM gross profit for Novartis AG?
Novartis AG all-time high TTM gross profit is $40.45B
What is Novartis AG TTM gross profit year-on-year change?
Over the past year, NVS TTM gross profit has changed by +$2.44B (+6.70%)